Assembly Biosciences Inc $ 5.88 -0.06 (-1.01%)
Volume:
1,097,888
Avg Vol (1m):
909,404
Market Cap $:
194.17 Mil
Enterprise Value $:
-32,997,000.00
P/E (TTM):
0.00
P/B:
0.77
Financial Strength | 6/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 22.09 | ||
| Equity-to-Asset | 0.88 | ||
| Debt-to-Equity | 0.04 | ||
| Debt-to-EBITDA | -0.2 | ||
| Piotroski F-Score | 4 | ||
| Altman Z-Score | 1.77 | ||
| Beneish M-Score | 1.17 | ||
| WACC vs ROIC | |||
Profitability Rank | 1/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | -64.97 | ||
| Net Margin % | -60.14 | ||
| ROE % | -20.43 | ||
| ROA % | -16.86 | ||
| ROC (Joel Greenblatt) % | -402.09 | ||
| 3-Year EBITDA Growth Rate | -14.1 | ||
| 3-Year EPS without NRI Growth Rate | -13.1 |
ASMB
Valuation Rank |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PB Ratio | 0.77 | ||
| PS Ratio | 2.54 | ||
| EV-to-EBIT | 0.61 | ||
| EV-to-EBITDA | 0.62 | ||
| EV-to-Revenue | -0.4 | ||
| Current Ratio | 14.66 | ||
| Quick Ratio | 14.66 | ||
| Days Sales Outstanding | 15.82 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -23.6 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 0.91 | ||
| Earnings Yield (Greenblatt) % | 163.93 |